September 9, 2016
A key drug review committee of the Ministry of Health, Labor and Welfare (MHLW) on September 7 recommended approval for a batch of drugs including Nippon Boehringer Ingelheim’s triple combo hypertension drug. At meetings in April and May, the Pharmaceutical...read more